Mirae Asset Global Investments Co., Ltd. Entrada Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,246 shares of TRDA stock, worth $16,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,246Holding current value
$16,609% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$64.9 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$59 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$58.8 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$40.7 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$22.8 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $418M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...